Author

P. A. Aas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1

Frequent Co-Authors

A. Ianevski· 2 shared D. E. Kainov· 2 shared E. Zusinaite· 2 shared H. Lysvand· 2 shared M. Bjoras· 2 shared M. H. Fenstad· 2 shared R. Yao· 2 shared S. A. Nordbo· 2 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Ianevski

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Identification of novel antiviral drug combinations in vitro and tracking their development

A. Ianevski, R. Yao, S. Biza, E. Zusinaite, A. Mannik, G. Kivi, A. Planken, K. Kurg, E.-M. Tombak, M. Ustav, N. Shtaida, E. Kulesskiy, E. Jo, J. Yang, H. Lysvand, , D. E. Kainov

This study identifies novel synergistic antiviral drug combinations effective against SARS-CoV-2, echovirus 1, HCV, and HIV-1 in vitro and provides an online resource for their developmental status.

bioRxiv · Sep 17, 2020 · PreprintMicrobiology

Potential antiviral options against SARS-CoV-2 infection

A. Ianevski, R. Yao, M. H. Fenstad, S. Biza, E. Zusinaite, H. Lysvand, K. Loeseth, V. M. Lamndsem, J. F. Malmring, V. Oksenych, S. E. Erlandsen, P. A. Aas, L. Hagen, C. H. Pettersen, J. E. Afset, , D. E. Kainov

The paper identifies potent convalescent sera and broad-spectrum antivirals effective against SARS-CoV-2 using a neutralization assay and cell culture screening.

bioRxiv · May 12, 2020Microbiology